pritelivir

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2017
012320132017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Pritelivir, a helicase-primase inhibitor, has excellent in vitro and in vivo activity against human herpes simplex virus (HSV… (More)
Is this relevant?
2017
2017
A series of congeners structurally related to pritelivir, N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2… (More)
Is this relevant?
2017
2017
Valacyclovir and famciclovir enabled successful systemic therapy for treating herpes simplex virus (HSV) and varicella zoster… (More)
Is this relevant?
2016
2016
Pharmacokinetic and pharmacodynamic models estimate the potency of antiviral agents but do not capture viral and immunologic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
Importance Current therapy of herpes infections relies on nucleoside analogues. Pritelivir is a well-tolerated novel herpes… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2016
2016
BACKGROUND Pritelivir is a novel helicase-primase inhibitor in clinical development for treatment of herpes simplex virus type 2… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
2014
2014
BACKGROUND Pritelivir, an inhibitor of the viral helicase-primase complex, exhibits antiviral activity in vitro and in animal… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2014
2014
Herpes simplex virus (HSV) infections can cause considerable morbidity. Transmission of HSV-2 has become a major health concern… (More)
Is this relevant?
2014
2014
Two medications are licensed in the United States for the treatment of infection with gen­ ital herpes simplex virus (HSV… (More)
  • figure 1
Is this relevant?
2013
2013
Fifty-nine US isolates of HSV-1 and HSV-2 obtained between 1998 and 2004 were tested for sensitivity to the helicase-primase… (More)
Is this relevant?